Sandra Hoegl1, Bernhard Zwissler, Holger K Eltzschig, Christine Vohwinkel. 1. aOrgan Protection Program, Department of Anesthesiology, University of Colorado School of Medicine, Aurora, Colorado, USA bDepartment of Anesthesiology and Comprehensive Pneumology Center Munich (CPC-M), German Center for Lung Research, University Hospital, Ludwig-Maximilians-University, Munich, Germany cDepartment of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado, USA.
Abstract
PURPOSE OF REVIEW: This review gives an update on current treatment options and novel concepts on the prevention and treatment of the acute respiratory distress syndrome (ARDS) in cardiovascular surgery patients. RECENT FINDINGS: The only proven beneficial therapeutic options in ARDS are those that help to prevent further ventilator-induced lung injury, such as prone position, use of lung-protective ventilation strategies, and extracorporeal membrane oxygenation. In the future also new approaches like mesenchymal cell therapy, activation of hypoxia-elicited transcription factors or targeting of purinergic signaling may be successful outside the experimental setting. Owing to the so far limited treatment options, it is of great importance to determine patients at risk for developing ARDS already perioperatively. In this context, serum biomarkers and lung injury prediction scores could be useful. SUMMARY: Preventing ARDS as a severe complication in the cardiovascular surgery setting may help to reduce morbidity and mortality. As cardiovascular surgery patients are of greater risk to develop ARDS, preventive interventions should be implemented early on. Especially, use of low tidal volumes, avoiding of fluid overload and restrictive blood transfusion regimes may help to prevent ARDS.
PURPOSE OF REVIEW: This review gives an update on current treatment options and novel concepts on the prevention and treatment of the acute respiratory distress syndrome (ARDS) in cardiovascular surgery patients. RECENT FINDINGS: The only proven beneficial therapeutic options in ARDS are those that help to prevent further ventilator-induced lung injury, such as prone position, use of lung-protective ventilation strategies, and extracorporeal membrane oxygenation. In the future also new approaches like mesenchymal cell therapy, activation of hypoxia-elicited transcription factors or targeting of purinergic signaling may be successful outside the experimental setting. Owing to the so far limited treatment options, it is of great importance to determine patients at risk for developing ARDS already perioperatively. In this context, serum biomarkers and lung injury prediction scores could be useful. SUMMARY: Preventing ARDS as a severe complication in the cardiovascular surgery setting may help to reduce morbidity and mortality. As cardiovascular surgery patients are of greater risk to develop ARDS, preventive interventions should be implemented early on. Especially, use of low tidal volumes, avoiding of fluid overload and restrictive blood transfusion regimes may help to prevent ARDS.
Authors: Ognjen Gajic; Ousama Dabbagh; Pauline K Park; Adebola Adesanya; Steven Y Chang; Peter Hou; Harry Anderson; J Jason Hoth; Mark E Mikkelsen; Nina T Gentile; Michelle N Gong; Daniel Talmor; Ednan Bajwa; Timothy R Watkins; Emir Festic; Murat Yilmaz; Remzi Iscimen; David A Kaufman; Annette M Esper; Ruxana Sadikot; Ivor Douglas; Jonathan Sevransky; Michael Malinchoc Journal: Am J Respir Crit Care Med Date: 2010-08-27 Impact factor: 21.405
Authors: Herbert P Wiedemann; Arthur P Wheeler; Gordon R Bernard; B Taylor Thompson; Douglas Hayden; Ben deBoisblanc; Alfred F Connors; R Duncan Hite; Andrea L Harabin Journal: N Engl J Med Date: 2006-05-21 Impact factor: 91.245
Authors: Brian M Fuller; Nicholas M Mohr; Lee Skrupky; Susan Fowler; Marin H Kollef; Christopher R Carpenter Journal: Chest Date: 2015-06 Impact factor: 9.410
Authors: Antoine Vieillard-Baron; Cyril Charron; Vincent Caille; Guillaume Belliard; Bernard Page; François Jardin Journal: Chest Date: 2007-10-09 Impact factor: 9.410
Authors: Thomas Weig; Silke Janitza; Michael Zoller; Michael E Dolch; Jens Miller; Lorenz Frey; Nikolaus Kneidinger; Thorsten Johnson; Mirjam I Schubert; Michael Irlbeck Journal: J Crit Care Date: 2014-02-25 Impact factor: 3.425
Authors: V Marco Ranieri; Gordon D Rubenfeld; B Taylor Thompson; Niall D Ferguson; Ellen Caldwell; Eddy Fan; Luigi Camporota; Arthur S Slutsky Journal: JAMA Date: 2012-06-20 Impact factor: 56.272
Authors: Kelsey G Iguidbashian; Justin Robison; Ludmila Khailova; James Jaggers; Richard Ing; Scott Lawson; Suzanne M Osorio Lujan; Jelena Klawitter; Jesse A Davidson Journal: Pediatr Res Date: 2022-06-09 Impact factor: 3.953
Authors: Jessica N Persson; Christine H Baird; Suhong Tong; Tracy T Urban; Jelena Klawitter; Paul E Wischmeyer; Jesse A Davidson Journal: Pediatr Res Date: 2018-01-17 Impact factor: 3.756